Cargando…

Noninvasive assessment of bone health in Indian patients with chronic kidney disease

Abnormalities in mineral and bone disease are common in chronic kidney disease (CKD). Evaluation of bone health requires measurement of parameters of bone turnover, mineralization, and volume. There are no data on bone health in CKD patients from India. In this cross-sectional study, we evaluated se...

Descripción completa

Detalles Bibliográficos
Autores principales: Jabbar, Z., Aggarwal, P. K., Chandel, N, Khandelwal, N., Kohli, H. S., Sakhuja, V., Jha, V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3692139/
https://www.ncbi.nlm.nih.gov/pubmed/23814412
http://dx.doi.org/10.4103/0971-4065.111831
_version_ 1782274578929680384
author Jabbar, Z.
Aggarwal, P. K.
Chandel, N
Khandelwal, N.
Kohli, H. S.
Sakhuja, V.
Jha, V.
author_facet Jabbar, Z.
Aggarwal, P. K.
Chandel, N
Khandelwal, N.
Kohli, H. S.
Sakhuja, V.
Jha, V.
author_sort Jabbar, Z.
collection PubMed
description Abnormalities in mineral and bone disease are common in chronic kidney disease (CKD). Evaluation of bone health requires measurement of parameters of bone turnover, mineralization, and volume. There are no data on bone health in CKD patients from India. In this cross-sectional study, we evaluated serum biomarkers of bone turnover: Bone-specific alkaline phosphatase (BAP) and total deoxypyridinoline (tDPD) along with parathyroid hormone, 25(OH) vitamin D, and bone mineral density (BMD) using dual absorption X-ray absorptiometry in a cohort of 74 treatment-naive patients with newly diagnosed stage 4 and 5 CKD (age 42 ± 14.5 years, 54 men) and 52 non-CKD volunteers (age 40.2 ± 9.3 years, 40 men). Compared to the controls, CKD subjects showed elevated intact PTH (iPTH), BAP, and tDPD and lower BMD. There was a strong correlation between iPTH and BAP (r = 0.88, P < 0.0001), iPTH and tDPD (r = 0.51, P < 0.0001), and BAP and tDPD (r = 0.46, P = 0.0004). The iPTH elevation was greater than twice the upper range of normal in 73% cases, and BAP was >40 U/L in 66% cases. The combination of these markers suggests high turnover bone disease in over 60% cases. The prevalence of osteopenia and osteoporosis was 37% and 12%, respectively. Osteoporotic subjects had higher iPTH, BAP, and tDPD, suggesting a role of high turnover in genesis of osteoporosis. Vitamin D deficiency was seen in 80%, and another 13% had insufficient levels. Vitamin D correlated inversely with BAP (r = −0.3, P = 0.009), and levels were lower in those with iPTH >300 pg/ml (P = 0.0.04). In conclusion, over 60% of newly diagnosed Indian stage 4–5 CKD patients show biochemical parameters consistent with high turnover bone disease. High turnover could contribute to the development of osteoporosis in CKD subjects. Deficiency of 25 (OH) vitamin D is widespread and seems to have a role in the genesis of renal bone disease. Studies on the effect of supplementation of native vitamin D are needed.
format Online
Article
Text
id pubmed-3692139
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-36921392013-06-28 Noninvasive assessment of bone health in Indian patients with chronic kidney disease Jabbar, Z. Aggarwal, P. K. Chandel, N Khandelwal, N. Kohli, H. S. Sakhuja, V. Jha, V. Indian J Nephrol Original Article Abnormalities in mineral and bone disease are common in chronic kidney disease (CKD). Evaluation of bone health requires measurement of parameters of bone turnover, mineralization, and volume. There are no data on bone health in CKD patients from India. In this cross-sectional study, we evaluated serum biomarkers of bone turnover: Bone-specific alkaline phosphatase (BAP) and total deoxypyridinoline (tDPD) along with parathyroid hormone, 25(OH) vitamin D, and bone mineral density (BMD) using dual absorption X-ray absorptiometry in a cohort of 74 treatment-naive patients with newly diagnosed stage 4 and 5 CKD (age 42 ± 14.5 years, 54 men) and 52 non-CKD volunteers (age 40.2 ± 9.3 years, 40 men). Compared to the controls, CKD subjects showed elevated intact PTH (iPTH), BAP, and tDPD and lower BMD. There was a strong correlation between iPTH and BAP (r = 0.88, P < 0.0001), iPTH and tDPD (r = 0.51, P < 0.0001), and BAP and tDPD (r = 0.46, P = 0.0004). The iPTH elevation was greater than twice the upper range of normal in 73% cases, and BAP was >40 U/L in 66% cases. The combination of these markers suggests high turnover bone disease in over 60% cases. The prevalence of osteopenia and osteoporosis was 37% and 12%, respectively. Osteoporotic subjects had higher iPTH, BAP, and tDPD, suggesting a role of high turnover in genesis of osteoporosis. Vitamin D deficiency was seen in 80%, and another 13% had insufficient levels. Vitamin D correlated inversely with BAP (r = −0.3, P = 0.009), and levels were lower in those with iPTH >300 pg/ml (P = 0.0.04). In conclusion, over 60% of newly diagnosed Indian stage 4–5 CKD patients show biochemical parameters consistent with high turnover bone disease. High turnover could contribute to the development of osteoporosis in CKD subjects. Deficiency of 25 (OH) vitamin D is widespread and seems to have a role in the genesis of renal bone disease. Studies on the effect of supplementation of native vitamin D are needed. Medknow Publications & Media Pvt Ltd 2013 /pmc/articles/PMC3692139/ /pubmed/23814412 http://dx.doi.org/10.4103/0971-4065.111831 Text en Copyright: © Indian Journal of Nephrology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Jabbar, Z.
Aggarwal, P. K.
Chandel, N
Khandelwal, N.
Kohli, H. S.
Sakhuja, V.
Jha, V.
Noninvasive assessment of bone health in Indian patients with chronic kidney disease
title Noninvasive assessment of bone health in Indian patients with chronic kidney disease
title_full Noninvasive assessment of bone health in Indian patients with chronic kidney disease
title_fullStr Noninvasive assessment of bone health in Indian patients with chronic kidney disease
title_full_unstemmed Noninvasive assessment of bone health in Indian patients with chronic kidney disease
title_short Noninvasive assessment of bone health in Indian patients with chronic kidney disease
title_sort noninvasive assessment of bone health in indian patients with chronic kidney disease
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3692139/
https://www.ncbi.nlm.nih.gov/pubmed/23814412
http://dx.doi.org/10.4103/0971-4065.111831
work_keys_str_mv AT jabbarz noninvasiveassessmentofbonehealthinindianpatientswithchronickidneydisease
AT aggarwalpk noninvasiveassessmentofbonehealthinindianpatientswithchronickidneydisease
AT chandeln noninvasiveassessmentofbonehealthinindianpatientswithchronickidneydisease
AT khandelwaln noninvasiveassessmentofbonehealthinindianpatientswithchronickidneydisease
AT kohlihs noninvasiveassessmentofbonehealthinindianpatientswithchronickidneydisease
AT sakhujav noninvasiveassessmentofbonehealthinindianpatientswithchronickidneydisease
AT jhav noninvasiveassessmentofbonehealthinindianpatientswithchronickidneydisease